Author:
Liu W.,Li H.,Zhang J. X.,Xu Y. N.,Zhang X. M.,Shi J. S.,Koffas M. A. G.,Xu Z. H.
Funder
The National Key R & D Program of China
Tianjin Synthetic Biotechnology Innovation Capacity Improvement Project
The National Natural Science Foundation of China
Fundamental Research Funds for the Central Universities
Qing Lan Project in Jiangsu Province
Publisher
Springer Science and Business Media LLC
Reference32 articles.
1. Donova MV. Steroid bioconversions. In: Barredo J-L, Herráiz I, editors. Microbial steroids. New York: Springer; 2017. p. 1–13.
2. Fernández-Cabezón L, Galán B, García JL. New insights on steroid biotechnology. Front Microbiol. 2018;9:958–73. https://doi.org/10.3389/fmicb.2018.00958.
3. Teixeira MP, Passos EF, Haddad NF, et al. In vitro antitumoral effects of the steroid ouabain on human thyroid papillary carcinoma cell lines. Environ Toxicol. 2021;36(7):1338–48. https://doi.org/10.1002/tox.23130.
4. Liu Z, Liu T, Li W, et al. Insights into the antitumor mechanism of ginsenosides Rg3. Mol Biol Rep. 2021;48(3):2639–52. https://doi.org/10.1007/s11033-021-06187-2.
5. Frye CA. Steroids, reproductive endocrine function, and affect. A review. Minerva Ginecol. 2009;61(6):541–62.